BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 11236112)

  • 1. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour. The Worldwide Atosiban versus Beta-agonists Study Group.
    Worldwide Atosiban versus Beta-agonists Study Group
    BJOG; 2001 Feb; 108(2):133-42. PubMed ID: 11236112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The oxytocin antagonist atosiban versus the beta-agonist terbutaline in the treatment of preterm labor. A randomized, double-blind, controlled study.
    European Atosiban Study Group
    Acta Obstet Gynecol Scand; 2001 May; 80(5):413-22. PubMed ID: 11328217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre, parallel group, randomised, single-blind study of the safety and efficacy of atosiban versus ritodrine in the treatment of acute preterm labour in Korean women.
    Shim JY; Park YW; Yoon BH; Cho YK; Yang JH; Lee Y; Kim A
    BJOG; 2006 Nov; 113(11):1228-34. PubMed ID: 16978233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol.
    French/Australian Atosiban Investigators Group
    Eur J Obstet Gynecol Reprod Biol; 2001 Oct; 98(2):177-85. PubMed ID: 11574128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effectiveness and safety of atosiban vs. pulsatile administration of fenoterol in the treatment of preterm labour].
    Nonnenmacher A; Hopp H; Dudenhausen J
    Z Geburtshilfe Neonatol; 2009 Oct; 213(5):201-6. PubMed ID: 19856243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pragmatic comparison of beta2-agonist side effects within the Worldwide Atosiban versus Beta Agonists study.
    Chan J; Cabrol D; Ingemarsson I; Marsal K; Moutquin JM; Fisk NM
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):135-41. PubMed ID: 16504369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice evaluation of combination of atosiban, ritodrine and ketoprofen for inhibiting preterm labor.
    Grignaffini A; Soncini E; Ronzoni E; Lo Cane F; Anfuso S; Nardelli GB
    Minerva Ginecol; 2007 Oct; 59(5):481-9. PubMed ID: 17912174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: a multicenter effectiveness and safety study.
    Moutquin JM; Sherman D; Cohen H; Mohide PT; Hochner-Celnikier D; Fejgin M; Liston RM; Dansereau J; Mazor M; Shalev E; Boucher M; Glezerman M; Zimmer EZ; Rabinovici J
    Am J Obstet Gynecol; 2000 May; 182(5):1191-9. PubMed ID: 10819857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience of using oxytocin antagonist atosiban in the rescue therapy of preterm labour].
    Tan JP; Chen H; Du BJ; Liu YL; Wang YH; Zhang JP
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):81-4. PubMed ID: 18683742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of spontaneous preterm labor in Taiwanese women.
    Lin CH; Lin SY; Shyu MK; Chen SU; Lee CN
    J Formos Med Assoc; 2009 Jun; 108(6):493-501. PubMed ID: 19515630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice evaluation of atosiban in preterm labour management in six European countries.
    Husslein P; Roura LC; Dudenhausen J; Helmer H; Frydman R; Rizzo N; Schneider D;
    BJOG; 2006 Dec; 113 Suppl 3():105-10. PubMed ID: 17206976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atosiban versus usual care for the management of preterm labor.
    Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
    J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and introduction of anti-oxytocic tocolytics.
    Lamont RF
    BJOG; 2003 Apr; 110 Suppl 20():108-12. PubMed ID: 12763125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin receptor antagonists for inhibiting preterm labour.
    Flenady V; Reinebrant HE; Liley HG; Tambimuttu EG; Papatsonis DN
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD004452. PubMed ID: 24903678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of atosiban and ritodrine in external cephalic version.
    Stergiotou I; Talbot F; Yoong W
    Acta Obstet Gynecol Scand; 2007; 86(8):927-9. PubMed ID: 17653876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial.
    Van De Water M; Kessel ET; De Kleine MJ; Oei SG
    Acta Obstet Gynecol Scand; 2008; 87(3):340-5. PubMed ID: 18307075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atosiban and nifedipine in acute tocolysis: a comparative study.
    Al-Omari WR; Al-Shammaa HB; Al-Tikriti EM; Ahmed KW
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):129-34. PubMed ID: 16446025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of preterm labor with the oxytocin antagonist atosiban.
    Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
    Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
    Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.